This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2014.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. Momenta Pharmaceuticals next reports earnings on May 06, 2014.
To receive a free e-mail notification whenever Momenta Pharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
Momenta: Entry Into A Material Definitive Agreement - July 18, 2014